Skip to main content

Bellafill to Replace ArteFill as New Brand

San Diego, CA - Dec. 1, 2014 - Suneva Medical, Inc., a privately-held aesthetics company, today announced that ArteFill, a dermal filler, has been rebranded as Bellafill in the U.S. "We feel that the brand Bellafill better embodies the transformational outcomes this unique product can provide to our customers and their patients," said Suneva Medical's Chairman and Chief Executive Officer, Nicholas L. Teti, Jr. "In addition, Suneva will build and invest in Bellafill to increase awareness for the new brand." Bellafill is approved by the U.S. Food and Drug Administration for the correction of facial wrinkles known as nasolabial folds, or smile lines. Proven safe and effective, the dermal filler is comprised of 80 percent purified bovine collagen with 20 percent polymethylmethacrylate (PMMA) microspheres, and lidocaine. In addition to immediately adding volume to smooth away smile lines, Bellafill® helps skin re-create its own firmer structure for beautiful, younger looking skin and lasting results.1,2.

About Suneva Medical, Inc.

Suneva Medical, Inc. is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the general dermatology and aesthetic markets. The company currently markets Bellafill® in the U.S. and Canada; ArteFill® in Korea and Singapore; Regenica® in the U.S. and Canada; and ReFissa® in the U.S. For more information, visit www.sunevamedical.com.

References

  1. Gottfried Lemperle, et. al., ArteFill® Permanent Injectable for Soft Tissue Augmentation: I. Mechanism of Action and Injection Techniques., Aesthetic Plast Surg. 2010 Jun;34(3):264–72.
  2. Data on file, Suneva Medical Inc.

Posted: December 2014

Related articles

Bellafill (dermal filler) FDA Approval History

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.